4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000272
Director sold 28,000 shares at an average $74.02 ($2,072,578)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WENDER JOSEPH H · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-30 | Sale : show line 1 in the form 10b5-1 | −2,484 | $72.19 | $179,320 | 89,551 | I |
| 2025-10-30 | Sale : show line 2 in the form 10b5-1 | −8,341 | $73.16 | $610,228 | 81,210 | I |
| 2025-10-30 | Sale : show line 3 in the form 10b5-1 | −5,975 | $73.85 | $441,254 | 75,235 | I |
| 2025-10-31 | Sale : show line 4 in the form 10b5-1 | −11,200 | $75.16 | $841,776 | 64,035 | I |
| Open-market sales · 28,000 sh · avg $74.02 · $2,072,578 | ||||||
Loading xslF345X05/edgardoc.xml…